These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15742421

  • 1. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
    Feng LY, Yao XX, Jiang SL.
    World J Gastroenterol; 2005 Feb 21; 11(7):1083-6. PubMed ID: 15742421
    [Abstract] [Full Text] [Related]

  • 2. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr 21; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 3. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Apr 21; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S.
    Helicobacter; 2001 Sep 21; 6(3):254-61. PubMed ID: 11683930
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
    Isomoto H, Furusu H, Ohnita K, Wen CY, Inoue K, Kohno S.
    World J Gastroenterol; 2005 Mar 21; 11(11):1629-33. PubMed ID: 15786539
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study.
    Kumar D, Ahuja V, Dhar A, Sharma MP.
    Indian J Gastroenterol; 2001 Mar 21; 20(5):191-4. PubMed ID: 11676331
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
    Maconi G, Russo A, Imbesi V, Cucino C, Bianchi Porro G.
    Dig Liver Dis; 2000 May 21; 32(4):275-80. PubMed ID: 11515622
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G, Wittig J, Ammon S, Walker S, van Doorn LJ, Klotz U.
    Arch Intern Med; 2002 Jan 28; 162(2):153-60. PubMed ID: 11802748
    [Abstract] [Full Text] [Related]

  • 12. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
    Uemura N, Okamoto S, Mukai T, Yamaguchi S, Kaji M, Hrruma K, Sumii K, Kajiyama G.
    Eur J Gastroenterol Hepatol; 1995 Aug 28; 7 Suppl 1():S67-9. PubMed ID: 8574740
    [Abstract] [Full Text] [Related]

  • 13. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF, Carvalhaes A, Natan-Eisig J, Paraíso-Ferraz JG, Trevisan M, Zaterkaad S.
    Gastroenterol Hepatol; 2005 Oct 28; 28(8):441-4. PubMed ID: 16185577
    [Abstract] [Full Text] [Related]

  • 14. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
    Lai YC, Wang TH, Huang SH, Yang SS, Wu CH, Chen TK, Lee CL.
    World J Gastroenterol; 2003 Jul 28; 9(7):1537-40. PubMed ID: 12854158
    [Abstract] [Full Text] [Related]

  • 15. The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.
    Kim JI, Park SH, Kim JK, Chung IS, Chung KW, Sun HS.
    Helicobacter; 2002 Dec 28; 7(6):331-6. PubMed ID: 12485118
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
    Lindsetmo RO, Johnsen R, Revhaug A.
    Scand J Gastroenterol; 1998 Mar 28; 33(3):231-5. PubMed ID: 9548613
    [Abstract] [Full Text] [Related]

  • 17. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
    Takimoto T, Kimura K, Taniguchi Y, Satoh K, Saifuku K, Kihira K, Yoshida Y, Ido K.
    Eur J Gastroenterol Hepatol; 1995 Aug 28; 7 Suppl 1():S63-6. PubMed ID: 8574739
    [Abstract] [Full Text] [Related]

  • 18. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M, Massarrat S, Zare S, Fattahi M, Javan A, Etaati H, Dehbashi N.
    Am J Gastroenterol; 1995 Sep 28; 90(9):1419-23. PubMed ID: 7661161
    [Abstract] [Full Text] [Related]

  • 19. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A, Kadayifçi A, Yeşilova Z, Savaş MC, Ateş Y, Karslioğlu Y, Ciğerim M, Bağci S, Dağalp K.
    Turk J Gastroenterol; 2004 Dec 28; 15(4):219-24. PubMed ID: 16249974
    [Abstract] [Full Text] [Related]

  • 20. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
    Di Mario F, Battaglia F, Dal Bò N, Leandro G, Benedetti E, Bottona E, Caroli A, Costan-Biedo F, De Bastiani R, Germanà B, Andrea Grassi S, Madia D, Marcon V, Marin R, Monica F, Olivieri P, Orzes N, Pilotto A, Ronzani G, Saggioro A, Tafner G.
    Dig Liver Dis; 2000 Mar 28; 32(2):108-15. PubMed ID: 10975783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.